AVROBIO, Inc. (AVRO): Price and Financial Metrics
AVROBIO, Inc. (AVRO)
Today's Latest Price: $13.50 USD
0.30 (-2.17%)
Updated Dec 2 6:55pm
Add AVRO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
AVRO Stock Price Chart Interactive Chart >
AVRO Price/Volume Stats
| Current price | $13.50 | 52-week high | $29.32 |
| Prev. close | $13.80 | 52-week low | $9.76 |
| Day low | $13.27 | Volume | 576,400 |
| Day high | $13.84 | Avg. volume | 295,631 |
| 50-day MA | $14.95 | Dividend yield | N/A |
| 200-day MA | $16.60 | Market Cap | 492.09M |
AVROBIO, Inc. (AVRO) Company Bio
AVROBIO, Inc., a clinical stage gene therapy company, focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. It lead product candidate in AVR-RD-01, which is in Phase 1 clinical trial for the treatment of Fabry disease. The company is also developing AVR-RD-02 for the treatment of Gaucher disease; AVR-RD-03 for the treatment of Pompe disease; and AVR-RD-04 for the treatment of cystinosis. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...